logo
ResearchBunny Logo
Dual role of Ca²⁺-activated Cl⁻ channel transmembrane member 16A in lipopolysaccharide-induced intestinal epithelial barrier dysfunction in vitro

Medicine and Health

Dual role of Ca²⁺-activated Cl⁻ channel transmembrane member 16A in lipopolysaccharide-induced intestinal epithelial barrier dysfunction in vitro

J. Sui, C. Zhang, et al.

This study unveils the intriguing dual role of TMEM16A in intestinal epithelial barrier function amidst LPS-induced damage. Conducted by a team of researchers from Dalian Medical University, the findings reveal how TMEM16A exacerbates dysfunction with low LPS doses while providing protection at higher doses, challenging our understanding of epithelial responses to inflammation.

00:00
00:00
~3 min • Beginner • English
Abstract
Dysfunction of intestinal epithelial Cl⁻ currents and channels have previously been reported in inflammatory intestinal diseases. However, the expression and function of the newly identified Ca²⁺-activated Cl⁻ channel transmembrane member 16A (TMEM16A) in the intestinal epithelium is unclear. In this study, we investigated the effects of TMEM16A on intestinal epithelial barrier function in vitro. Intestinal epithelial barrier dysfunction was modeled by lipopolysaccharide (LPS)-induced cell damage in intestinal epithelial IEC-6 cells and the effects of TMEM16A knockdown and overexpression on cell apoptosis and tight junctions were studied. Corresponding mRNA and protein expression levels were measured by quantitative real-time polymerase chain reaction, western blotting, and immunofluorescence analysis, respectively. TMEM16A expression was significantly increased by LPS, possibly via a process involving the transcription factor nuclear factor-κB and both Th1 and Th2 cytokines. Low- and high-dose LPS dysregulated tight junctions (high-myosin light-chain kinase expression) and cell apoptosis-dependent cell barrier dysfunction, respectively. TMEM16A aggravated cell barrier dysfunction in IEC-6 cells pretreated with low-dose LPS by activating ERK1/MLCK signaling pathways, but protected against cell barrier dysfunction by activating ERK/Bcl-2/Bax signaling pathways in IEC-6 cells pretreated with high-dose LPS. We concluded that TMEM16A played a dual role in LPS-induced epithelial dysfunction in vitro. The present results indicated the complex regulatory mechanisms and targeting of TMEM16A may provide potential treatment strategies for intestinal epithelial barrier damage, as well as forming the basis for future studies of the expression and function of TMEM16A in normal and inflammatory intestinal diseases in vivo.
Publisher
Cell Death and Disease
Published On
May 29, 2020
Authors
Jingru Sui, Chi Zhang, Xuesheng Fang, Jianwen Wang, Yu Li, Jingyu Wang, Liang Wang, Jianyi Dong, Zijuan Zhou, Changyi Li, Jun Chen, Tonghui Ma, Dapeng Chen
Tags
TMEM16A
intestinal epithelial barrier
LPS
tight junction dysregulation
apoptosis
ERK signaling
barrier dysfunction
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny